- Home
- FLYE vs PPCB Comparison
FLYE vs PPCB Comparison
Compare FLYE & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FLYE | PPCB |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Aerospace | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 2.6M |
| IPO Year | 2024 | 2011 |
Fundamental Metrics
Financial Performance| Metric | FLYE | PPCB |
|---|---|---|
| Price | $2.17 | $1.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.7K | ★ 3.2M |
| Earning Date | 04-21-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.82 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,063,357.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.48 | $0.06 |
| 52 Week High | $21.80 | $6.79 |
Technical Indicators
Market Signals| Indicator | FLYE | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 65.23 | 47.02 |
| Support Level | $1.66 | $0.90 |
| Resistance Level | $2.30 | $1.38 |
| Average True Range (ATR) | 0.16 | 0.29 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 61.89 | 3.08 |
Price Performance
Historical ComparisonAbout FLYE Fly-E Group Inc.
Fly-E Group Inc is principally engaged in designing, installing, and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories under the Fly E-Bike brand. The Company encourages the adoption of eco-friendly transportation for active lifestyles.
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.